Brainsway Raises 2026 Outlook Following 35% Q2 Revenue Growth

Key Facts

In a move reflecting the accelerating expansion within the innovative medical device sector, Brainsway has announced robust financial results for the second quarter of 2026. The company reported a significant 35% year-over-year increase in revenue, directly attributed to surging demand for its Deep TMS systems. According to reports, the expansion of reimbursement for the SWIFT protocol and a growing installed base were key drivers behind this performance.

Driven by this strong momentum, management has raised its full-year 2026 revenue outlook, signaling increased confidence in its commercial trajectory. This growth occurs as the market shows rising appetite for advanced healthcare technology solutions, with the company leveraging the wider distribution of its systems to strengthen its competitive positioning.

Looking ahead, investors are monitoring the sustainability of this growth despite the current unavailability of updated BWAY price data. Broader economic indicators remain a factor, as recent calendar data showed U.S. Non-Farm Payrolls falling to -23k in August 2026, which may influence general market sentiment toward the growth and technology sectors.